Cargando…

The Influence of Diabetes Mellitus in Myocardial Ischemic Preconditioning

Ischemic preconditioning (IP) is a powerful mechanism of protection discovered in the heart in which ischemia paradoxically protects the myocardium against other ischemic insults. Many factors such as diseases and medications may influence IP expression. Although diabetes poses higher cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rezende, Paulo Cury, Rahmi, Rosa Maria, Hueb, Whady
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021496/ https://www.ncbi.nlm.nih.gov/pubmed/27656659 http://dx.doi.org/10.1155/2016/8963403

Ejemplares similares

Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients
por: Rezende, Paulo Cury, et al.
Publicado: (2015)

Effect of Hypoglycemic Agents on Ischemic Preconditioning in Patients With Type 2 Diabetes and Symptomatic Coronary Artery Disease
por: Rahmi, Rosa Maria, et al.
Publicado: (2013)

Myocardial injury in diabetic patients with multivessel coronary artery disease after revascularization interventions
por: Rezende, Paulo Cury, et al.
Publicado: (2017)

Hypotheses, rationale, design, and methods for evaluation of ischemic preconditioning assessed by sequential exercise tests in diabetic and non-diabetic patients with stable coronary artery disease – a prospective study
por: Rezende, Paulo Cury, et al.
Publicado: (2013)

Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease
por: Costa, Leandro M.A., et al.
Publicado: (2015)

Single Photon Computed Tomography-Myocardial Perfusion Scintigraphy. Diagnostic Tool Anticipating the Disease
por: Hueb, Whady
Publicado: (2019)

Association Between Stress Testing–Induced Myocardial Ischemia and Clinical Events in Patients With Multivessel Coronary Artery Disease
por: Garzillo, Cibele Larrosa, et al.
Publicado: (2019)

A case of mid-apical obstructive hypertrophic cardiomyopathy treated with a transapical myectomy approach: a case report
por: Scudeler, Thiago Luis, et al.
Publicado: (2014)

Troponin in diabetic patients with and without chronic coronary artery disease
por: Segre, Carlos Alexandre Wainrober, et al.
Publicado: (2015)

Effect of diabetic kidney disease on therapeutic strategies for coronary artery disease: ten year follow-up
por: Batista, Daniel Valente, et al.
Publicado: (2021)

Ischemic preconditioning: Protection against myocardial necrosis and apoptosis
por: Iliodromitis, Efstathios K, et al.
Publicado: (2007)

On-pump versus off-pump coronary artery bypass surgery in patients older than 60 years: five-year follow-up of MASS III trial
por: Vieira de Melo, Rodrigo Morel, et al.
Publicado: (2014)

Influence of diabetes mellitus duration on the efficacy of ischemic preconditioning in a Zucker diabetic fatty rat model
por: Hjortbak, Marie Vognstoft, et al.
Publicado: (2018)

Behavior of Ultrasensitive C-Reactive Protein in Myocardial Revascularization with and without Cardiopulmonary Bypass
por: Abrantes, Rafael Diniz, et al.
Publicado: (2018)

Long-term analysis of ventricular function in patients with symptomatic coronary disease who underwent on-pump or off-pump coronary artery bypass grafting
por: Silva, Rafael Rocha Mol, et al.
Publicado: (2022)

Abnormal elevation of myocardial necrosis biomarkers after coronary artery bypass grafting without established myocardial infarction assessed by cardiac magnetic resonance
por: Oikawa, Fernando Teiichi Costa, et al.
Publicado: (2017)

Association of Longitudinal Values of Glycated Hemoglobin With Cardiovascular Events in Patients With Type 2 Diabetes and Multivessel Coronary Artery Disease
por: Rezende, Paulo Cury, et al.
Publicado: (2020)

A practical approach to remote ischemic preconditioning and ischemic preconditioning against myocardial ischemia/reperfusion injury
por: Totzeck, Matthias, et al.
Publicado: (2016)

Significant elevation of biomarkers of myocardial necrosis after coronary artery bypass grafting without myocardial infarction established assessed by cardiac magnetic resonance
por: da Costa, Leandro Menezes Alves, et al.
Publicado: (2017)

Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial
por: Brandão, Sara Michelly Gonçalves, et al.
Publicado: (2018)

Better Technology, More Spending, Worse Outcomes
por: Hueb, Whady
Publicado: (2018)

Hypoglycemia and myocardial infarction: Inhibition of ischemic preconditioning response
por: Senthilkumaran, Subramanian, et al.
Publicado: (2012)

Remote ischemic preconditioning in myocardial protection in hemodialysis patients
por: Bacci, Marcelo R, et al.
Publicado: (2018)

Impact of diabetes mellitus on ischemic cardiomyopathy. Five-year follow-up. REVISION-DM trial
por: Hueb, Thiago, et al.
Publicado: (2018)

Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning
por: Miki, Takayuki, et al.
Publicado: (2012)

Clinical Applications of Remote Ischemic Preconditioning
por: Veighey, Kristin, et al.
Publicado: (2012)

Ischemic preconditioning: Interruption of various disorders
por: Goyal, Ahsas, et al.
Publicado: (2017)

Metabolic Reprogramming: Strategy for Ischemic Stroke Treatment by Ischemic Preconditioning
por: Liang, Jing, et al.
Publicado: (2021)

Remote liver ischemic preconditioning attenuates myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats
por: Liu, Xinhao, et al.
Publicado: (2021)

The Loss of Myocardial Benefit following Ischemic Preconditioning Is Associated with Dysregulation of Iron Homeostasis in Diet-Induced Diabetes
por: Vinokur, Vladimir, et al.
Publicado: (2016)

Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus
por: Sprandel, Marilia C O, et al.
Publicado: (2015)

Myocardial microstructure assessed by T1 mapping after on-pump and off-pump coronary artery bypass grafting
por: Dallazen, Anderson Roberto, et al.
Publicado: (2023)

Cardiac Troponin I in Patients Undergoing Percutaneous and Surgical Myocardial Revascularization: Comparison of Analytical Methods
por: Vendramini, Sabrina Pacheco do Amaral, et al.
Publicado: (2023)

Chronic troponin elevation assessed by myocardial T1 mapping in patients with stable coronary artery disease
por: Segre, Carlos Alexandre W., et al.
Publicado: (2023)

Sevoflurane, Propofol and Carvedilol Block Myocardial Protection by Limb Remote Ischemic Preconditioning
por: Cho, Youn Joung, et al.
Publicado: (2019)

Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injury
por: Weerateerangkul, Punate, et al.
Publicado: (2011)

Influence of Hyperglycemia and Diabetes on Cardioprotection by Humoral Factors Released after Remote Ischemic Preconditioning (RIPC)
por: Torregroza, Carolin, et al.
Publicado: (2021)

Sex is no determinant of cardioprotection by ischemic preconditioning in rats, but ischemic/reperfused tissue mass is for remote ischemic preconditioning
por: Lieder, Helmut R., et al.
Publicado: (2019)

Death and Myocardial Infarction Following Initial Revascularization Versus Optimal Medical Therapy in Chronic Coronary Syndromes With Myocardial Ischemia: A Systematic Review and Meta‐Analysis of Contemporary Randomized Controlled Trials
por: Soares, Andrea, et al.
Publicado: (2021)

Hyperbaric oxygen therapy and preconditioning for ischemic and hemorrhagic stroke
por: Hu, Sheng-li, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eaqlrj6khtopo0qcpv41v4g2hq